States / District of Columbia / HB 2230
HB 2230
Passed
Prescription Drug Pricing Sample data
Prescription Drug Price Reporting Requirements
Relating to prescription drug price reporting requirements; establishing filing, disclosure, and enforcement requirements; providing penalties.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
AI summary
Sample summary. HB 2230 would require covered entities in District of Columbia to file disclosures with the administering agency and would authorise civil penalties for non-compliance. Currently passed.
Bill text
| Version | Citation | Date | Words |
|---|---|---|---|
| Enrolled | HB 2230 (Enrolled) | Mar 18, 2026 | 514 |
History
Apr 17, 2026 · House
Reported from committee
Apr 10, 2026 · House
Public hearing held
Apr 8, 2026 · House
Read first time; referred to committee
Mar 24, 2026 · House
Filed